No Data
Bio-Thera Solutions, Ltd. (HKEX: 1875) has entered into a process development and manufacturing services agreement with Wuxi XDC (HKEX: 2268).
Dongyao Pharma-B (01875) and Wuxi XDC (02268) jointly announced that on June 16, 2026, Dongyao Pharma entered into a process development and manufacturing services agreement with Wuxi Bio, pursuant to which Dongyao Pharma will provide process development and manufacturing services to Wuxi Bio.
Wuxi XDC (02268.HK): Dongao Pharma and Wuxi Bio entered into a process development and manufacturing services agreement
Gelonghui, June 17 — Wuxi XDC (02268.HK) announced that on June 16, 2026, Dongyao Pharma entered into a Process Development and Manufacturing Services Agreement with Wuxi Bio, pursuant to which Dongyao Pharma will provide process development and manufacturing services to Wuxi Bio. Under the agreement, Dongyao Pharma agreed to provide process development and manufacturing services related to the production of monoclonal antibody intermediates. These services cover processes including cell thawing, cell passaging, N-stage cell culture, protein purification, excipient addition, and other preparation procedures for monoclonal antibody intermediates and other biological samples (“Process
Hong Kong-listed innovative drug stocks rose collectively, with Hengrui Pharma and Wuxi XDC up over 5%.
Gelonghui, June 12 | Hong Kong-listed innovative drug stocks rallied collectively, with RemeGen and Kelun Biotech rising over 8%, InnoCare Pharma up more than 7%, Confo Therapeutics gaining over 6%, Hengrui Pharma, Lepu Biopharma, Akeso, Sino Biopharm, and Wuxi XDC all increasing by more than 5%, and Simcere Pharmaceutical and Innovent Bio climbing over 4%.
BioDlink Shareholders Approve CDMO Master Agreement With WuXi XDC
Express News | Wuxi Apptec Responds to Being Listed by the U.S. as a 'Chinese Military Company': Will Immediately Take Steps to Challenge and Rectify This Erroneous Designation
Stronger Together, Shaping the Future | WuXi XDC and BioDlink Successfully Concluded 2026 Open Day